How Glass Transition Temperature (Tg) of PLGA Affects Drug Release and Formulation Stability
Introduction The Glass Transition Temperature (Tg) of PLGA is far more than a routine material specification. It functions as the […]
Nitrosamines in Transdermal Patches and Topical Formulations: Testing Challenges and Regulatory Expectations
Introduction: Why Nitrosamines in Transdermal Patches and Topical Formulations Require Specialized Attention Over the past several years, the pharmaceutical and
Tissue and CSF Bioanalytical Services for CNS Drug Development Programs
Introduction: Why Tissue and CSF Bioanalysis Is the Defining Step in CNS Drug Development One of the greatest challenges in
Tissue and CSF Bioanalytical Services for CNS Drug Development Programs Read More »
GC-MS vs LC-MS in Extractables and Leachables Testing: When to Use Each
Introduction: Why Technique Selection Is the Foundation of Every E&L Study In GC-MS vs LC-MS in Extractables and Leachables Testing,
GC-MS vs LC-MS in Extractables and Leachables Testing: When to Use Each Read More »
Insulin Biosimilar Characterization: Structural and Impurity Analysis Using LC-MS
Introduction: Why Insulin Biosimilar Characterization Demands Analytical Precision Insulin biosimilar characterization is far more than a routine regulatory requirement. It
Insulin Biosimilar Characterization: Structural and Impurity Analysis Using LC-MS Read More »
2D NMR Spectroscopy for Therapeutic Peptide Structural Characterization: COSY, TOCSY, and NOESY
Introduction: Why 2D NMR for Peptide Characterization Is an Essential Tool in Therapeutic Development When a therapeutic peptide progresses into
Case Study: Dual Analyte LC-MS/MS Bioanalysis for an Antibody-Drug Conjugate Program
Introduction: The Bioanalytical Complexity of ADC Programs Bioanalysis for an Antibody-Drug Conjugate Program is far from a straightforward analytical exercise.
Case Study: Dual Analyte LC-MS/MS Bioanalysis for an Antibody-Drug Conjugate Program Read More »
How to Build a Scientifically Justified AET for Extractables and Leachables (E&L) Studies
Introduction: Why AET Derivation Is the Defining Step in E&L Studies The Analytical Evaluation Threshold (AET) is the single most
Peptide Biosimilar Characterization Using LC-MS: Challenges and Analytical Solutions
Introduction: Why Peptide Biosimilar Characterization Using LC-MS Requires More Than Conventional Proteomics Peptide biosimilar characterization using LC-MS is far more
Peptide Biosimilar Characterization Using LC-MS: Challenges and Analytical Solutions Read More »
In Silico Potency Prediction for NDSRIs: Using SAR, DEREK, and CASE Ultra for Hazard Classification
Introduction: Why Conventional Mutagenicity Models Are Inadequate for NDSRIs The regulatory complexity associated with N-Nitrosamine Drug Substance-Related Impurities (NDSRIs) extends